The use of Bayesian statistical methods during drug development

By Philip Hougaard, Vice President, Biometrics, Lundbeck

Over the last few decades, Bayesian methods have gained momentum also within pharmaceutical drug development. During this talk, I will try to dig into this issue. This first covers how the Bayesian philosophy considers probability, parameters and populations. I will give my personal assessment of whether drug development has obtained a completely new paradigm or just an expansion of the statistical toolbox. This also includes a prioritized list of where Bayesian methods can add value compared to standard frequentist methods.

For more information and upcoming seminars see the abstracts go to

Unless otherwise stated, seminars will be held at CSS (det gamle Kommunehospital), Øster Farimagsgade 5, 1353 Copenhagen K, room 5.2.46. Tea will be served in the library of the section of Biostatistics half an hour before the seminar starts.